Cite
Soleimani A, Dadjoo P, Avan A, et al. Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond. Life Sci. 2022;120050doi: 10.1016/j.lfs.2021.120050.
Soleimani, A., Dadjoo, P., Avan, A., Soleimanpour, S., Rajabian, M., Ferns, G., Ryzhikov, M., Khazaei, M., & Hassanian, S. M. (2022). Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond. Life sciences, 120050. https://doi.org/10.1016/j.lfs.2021.120050
Soleimani, Atena, et al. "Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond." Life sciences vol. (2022): 120050. doi: https://doi.org/10.1016/j.lfs.2021.120050
Soleimani A, Dadjoo P, Avan A, Soleimanpour S, Rajabian M, Ferns G, Ryzhikov M, Khazaei M, Hassanian SM. Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond. Life Sci. 2022 Jan 10;120050. doi: 10.1016/j.lfs.2021.120050. Epub 2022 Jan 10. PMID: 35026215.
Copy
Download .nbib